Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-26

FDA Approved: OLANZAPINE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for Ascend Laboratories, LLC to market a generic olanzapine product under an ANDA. This marks the clearance of a generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)